<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: antiviral medication</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Estimates reveal low population immunity to new bird flu virus H7N9 in humans</title>
   	 <description>The level of immunity to the recently circulating H7N9 influenza virus in an urban and rural population in Vietnam is very low, according to the first population level study to examine human immunity to the virus, which was previously only found in birds. The findings have implications for planning the public health response to this pandemic threat.</description>
     <link>http://medicalxpress.com/news/2013-05-reveal-population-immunity-bird-flu.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 21 May 2013 11:46:37 EST</pubDate>
	 <guid isPermaLink="false">news288355588</guid>
	 
</item>
<item>
     <title>Sustained virological response linked with improved survival for patients with chronic HCV infection</title>
   	 <description>Among patients with chronic hepatitis C virus infection and advanced hepatic fibrosis (development of excess fibrous connective tissue), sustained virological response (SVR) to interferon-based treatment was associated with a lower risk of all-cause mortality compared with patients without SVR, according to a study in the December 26 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2012-12-sustained-virological-response-linked-survival.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 25 Dec 2012 16:00:02 EST</pubDate>
	 <guid isPermaLink="false">news275576845</guid>
	 
</item>
<item>
     <title>Adult antiviral drug effective in suppressing hepatitis B in teens</title>
   	 <description>A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases (AASLD), show that tenofovir DF suppressed HBV in 89% of pediatric participants.</description>
     <link>http://medicalxpress.com/news/2012-12-adult-antiviral-drug-effective-suppressing.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 05 Dec 2012 11:18:35 EST</pubDate>
	 <guid isPermaLink="false">news273928704</guid>
	 
</item>
<item>
     <title>U.S. task force: Baby boomers should be tested for hepatitis C</title>
   	 <description>(HealthDay)—A U.S. task force suggests that people at high risk for the hepatitis C virus should be screened, which includes those with a history of intravenous drug use and those who received blood transfusions before 1992.</description>
     <link>http://medicalxpress.com/news/2012-11-task-baby-boomers-hepatitis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 26 Nov 2012 19:30:01 EST</pubDate>
	 <guid isPermaLink="false">news273173066</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/ustaskforceb.jpg" width="90" height="90" />
</item>


</channel>
</rss>
